Indo Us Bio-Tech Intrinsic Value
INDOUS Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹43.33 | ₹39.00 - ₹47.66 | -63.7% | Book Value/Share: ₹43.33, P/B: 1.0x |
Want to compare with current market value? Check INDOUS share price latest .
Valuation Comparison Chart
INDOUS Intrinsic Value Analysis
What is the intrinsic value of INDOUS?
Based on our comprehensive analysis using 1 different valuation methods, the estimated intrinsic value of Indo Us Bio-Tech (INDOUS) is ₹43.33 (median value). With the current market price of ₹119.45, this represents a -63.7% variance from our estimated fair value.
The valuation range spans from ₹43.33 to ₹43.33, indicating ₹43.33 - ₹43.33.
Is INDOUS undervalued or overvalued?
Based on our multi-method analysis, Indo Us Bio-Tech (INDOUS) appears to be trading above calculated value by approximately 63.7%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 9.40 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Debt to Equity Ratio | 1.44 | Industry Standard: <0.5 | Above 1.0 | Indicates financial leverage level |
Related Pages for Indo Us Bio-Tech
Additional stock information and data for INDOUS
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2022 | ₹3 Cr | ₹1 Cr | Positive Free Cash Flow | 7/10 |
| March 2021 | ₹0 Cr | ₹-1 Cr | Negative Cash Flow | 3/10 |
| March 2020 | ₹-1 Cr | ₹-2 Cr | Negative Cash Flow | 3/10 |